The Effects of Malaria on the Human Body

Explore how the malaria parasite impacts human physiology, from destroying red blood cells to obstructing circulation in vital organs and the brain.

Malaria is not a disease that stays in one place. The parasite, once inside the bloodstream, systematically tears through red blood cells, triggers massive inflammation, clogs small blood vessels in the brain and other organs, suppresses the bone marrow, and can damage the liver, kidneys, lungs, and spleen. Even a case that looks uncomplicated on the surface often causes measurable liver injury and drops platelet counts dramatically. The most dangerous form, caused by Plasmodium falciparum, can kill within days by swelling the brain, collapsing blood sugar, or flooding the lungs with fluid. And some of the damage lingers long after the parasites are cleared.

How the Parasite Hijacks Red Blood Cells

Malaria’s defining trick is its ability to invade and live inside red blood cells. The blood-stage form of the parasite is restricted to red blood cells, using a specific set of surface proteins to latch onto and push its way inside the cell through an actin-powered motor. Once inside, the parasite does not simply sit quietly. It remodels the host cell extensively: the red blood cell loses its normal disc shape, its membrane becomes rigid, and its surface becomes sticky, particularly to the walls of blood vessels. These changes are not accidental. They help the parasite survive by allowing infected cells to anchor themselves in small blood vessels, avoiding the spleen’s filtration system that would otherwise destroy them.

As the parasite matures inside the red blood cell, it consumes hemoglobin for nutrients and eventually ruptures the cell to release a new wave of parasites. Each burst releases dozens of new merozoites that immediately seek out fresh red blood cells to invade. The cycle repeats roughly every 48 hours for P. falciparum, and each round destroys the host cell completely. But the damage goes beyond the cells the parasite directly infects.

Anemia From Multiple Directions

You might assume that malaria-related anemia simply comes from the parasite destroying the red blood cells it lives in. That accounts for some of it, but the body’s own immune response destroys far more uninfected cells than the parasite does directly. In rodent models of severe malarial anemia, the entire circulating blood supply was turned over in about one week, driven by immune-mediated clearance of healthy red blood cells rather than parasitic destruction alone. Depleting phagocytic cells or certain T cells significantly reduced the anemia in those experiments, confirming that the immune system itself was doing much of the damage.

On top of that accelerated destruction, the bone marrow’s ability to replace lost red blood cells is suppressed during and after infection. Persistent P. falciparum infection, even at levels too low to detect on a standard blood smear, was associated with significant bone marrow suppression in African children. The bone marrow also stops responding normally to erythropoietin, the hormone that signals the body to produce more red blood cells. This suppression occurs regardless of how anemic the patient already is, meaning that how bad the anemia gets depends mainly on how fast red cells are being destroyed peripherally, since the marrow cannot compensate. The result is a double hit: red blood cells are destroyed faster than normal and replaced slower than normal.

The Fever Cycle and What Drives It

Malaria’s hallmark cycling fevers are not random. They are timed to the parasite’s reproductive cycle inside red blood cells. When a generation of parasites finishes growing and bursts out of their host cells simultaneously, the debris triggers a massive inflammatory response. Among the molecules released during this rupture are phosphoantigens, which spill into the bloodstream and activate immune cells even at sites distant from where the parasites are sequestered.

The parasite also leaves behind hemozoin, a crystalline waste product formed from digesting hemoglobin. Hemozoin is rapidly engulfed by circulating monocytes and tissue macrophages, which respond by pumping out inflammatory signals like interleukin-1β. Here is where the immune system starts working against itself. After swallowing hemozoin, those same immune cells become partially disabled. Their oxidative burst capacity, the primary mechanism they use to kill pathogens, drops by roughly half within two hours and continues declining for at least 12 hours afterward. So hemozoin simultaneously triggers inflammation and cripples the immune cells that ate it, creating a state where the body is inflamed but poorly defended.

Clogged Blood Vessels and Cerebral Malaria

One of the most dangerous features of P. falciparum is its ability to make infected red blood cells stick to the walls of small blood vessels throughout the body, a process called cytoadherence. Infected cells also clump together with uninfected cells in formations called rosettes. Both behaviors contribute to vascular damage and provoke excessive immune responses in the organs where they accumulate. When this sequestration happens in the brain’s blood vessels, the result is cerebral malaria, the deadliest complication.

Cerebral malaria involves damage to the endothelial cells lining brain blood vessels, immune cell infiltration, hemorrhage, and breakdown of the blood-brain barrier. The brain swells. In children who die from cerebral malaria, increased brain volume is a consistent finding, while survivors tend to show only transient swelling that resolves. The raised intracranial pressure from this swelling is likely a direct contributor to fatal outcomes.

Clinicians have found a surprisingly useful window into what is happening in the brain: the retina. The retinal blood vessels are a direct extension of the cerebral circulation, making the eye the only place where you can directly observe the kind of vascular damage cerebral malaria causes in the brain. A specific pattern of retinal changes, called malarial retinopathy, has become an important biomarker for diagnosing cerebral malaria in children, since it correlates with disease severity and outcome.

Lasting Damage to the Brain

Surviving cerebral malaria does not always mean full recovery. About one in four children who survive cerebral malaria develop long-term cognitive impairments. These are not subtle deficits. They affect thinking, memory, and learning in ways that persist well beyond the acute illness. Severe malarial anemia, even without clear cerebral involvement, is also associated with persistent neurocognitive impairment in children. The mechanisms are still being investigated, but the combination of vascular obstruction, brain swelling, and sustained inflammation likely causes injury to developing neural tissue that the brain cannot fully repair.

Liver Injury Is More Common Than Most People Realize

The liver is often overlooked in malaria discussions, but an observational study found abnormal liver function tests in about 69% of patients with uncomplicated falciparum malaria on the day they were admitted. In severe disease, that figure rose to 87%. Most of the abnormalities in uncomplicated cases were mild, but about 5% were severe. The finding that matters here is that even malaria cases classified as uncomplicated are routinely injuring the liver. This is not just a feature of the worst cases.

The liver is also the initial staging ground for the parasite. After a mosquito bite, parasites travel to the liver first, invade liver cells, and multiply silently before bursting into the bloodstream. For P. vivax and P. ovale, some parasites form dormant stages called hypnozoites that can hide in liver cells for weeks, months, or even years before reactivating and causing relapse. Primaquine, the drug used to clear hypnozoites, does not immediately kill them but arrests their activation and prevents new blood-stage infections from emerging. This makes P. vivax infections notoriously difficult to cure completely, and people can suffer repeated bouts of illness long after leaving a malaria-endemic area.

Kidney Damage and Blackwater Fever

Severe malaria can destroy kidneys through several pathways, but one of the most dramatic is blackwater fever: a syndrome of massive intravascular hemolysis, where enormous numbers of red blood cells break apart inside blood vessels at once, spilling hemoglobin into the blood and urine. The name comes from the dark, cola-colored urine produced when free hemoglobin passes through the kidneys. This free hemoglobin is directly toxic to the kidney’s tubular cells, causing oxidative damage and inflammation that can lead to acute kidney injury. In hospitalized children with febrile illness, a history of blackwater fever was independently associated with roughly a twofold increase in the odds of severe acute kidney injury.

Lungs, Spleen, and Metabolic Collapse

Malaria can cause acute respiratory distress syndrome, a life-threatening condition where the lungs fill with fluid and oxygen exchange fails. In a ten-year study of adults with imported severe falciparum malaria at a Portuguese hospital, about a third of patients developed ARDS, typically around two days after starting antimalarial treatment. The timing is worth noting: lung complications often worsen even as the parasites are being killed, suggesting that the inflammatory cascade triggered by treatment and parasite death contributes to the damage. ARDS carries a high mortality rate, particularly in settings without advanced intensive care.

The spleen, which normally filters damaged and old red blood cells, goes into overdrive during malaria. In people living in endemic areas who experience repeated infections, the spleen can become massively enlarged in a condition called hyper-reactive malarial splenomegaly syndrome, driven by chronic overstimulation of the immune system from repeated exposure to parasite antigens. This is a leading cause of massive splenomegaly in malaria-endemic countries and creates a fragile situation: an enormous, blood-engorged spleen is vulnerable to rupture, which can be fatal.

Severe malaria also destabilizes basic metabolism. Hypoglycemia, dangerously low blood sugar, occurs through different mechanisms depending on age. In adults, it is often tied to quinine treatment, which stimulates insulin release and pushes glucose into cells too fast. In children, the problem is more about the body failing to produce enough glucose while simultaneously burning through it via anaerobic metabolism. High lactate levels build up when parasitized red blood cells clog microvascular beds throughout the body, starving tissues of oxygen and forcing them into less efficient metabolic pathways. Both hypoglycemia and lactic acidosis are independent predictors of death in severe malaria.

Blood Clotting Goes Haywire

Malaria disrupts the blood’s clotting system in ways that can cause both excessive clotting and dangerous bleeding. Activation of the clotting cascade is common, and in the worst cases it progresses to disseminated intravascular coagulation, a condition with very high mortality. Levels of natural anticoagulant proteins like protein C, protein S, and antithrombin drop during falciparum malaria. At the same time, endothelial cells become activated and release abnormally large clotting factors, while the enzyme that normally trims those factors down is reduced. The result can be spontaneous platelet clumping in small vessels and widespread microvascular disease.

Thrombocytopenia, a low platelet count, is one of the most reliable laboratory markers of malaria infection. In a study of patients along the Thailand-Myanmar border, about 85% of malaria-infected patients had low platelet counts, and having platelets below 150,000 per microliter made a person roughly 32 times more likely to have malaria compared to someone with a normal count. The drop in platelets is so consistent across malaria cases that it is sometimes used as a screening clue in febrile patients returning from endemic areas.

Malaria During Pregnancy

Pregnancy creates a unique vulnerability. P. falciparum-infected red blood cells express a special surface protein, VAR2CSA, that allows them to bind specifically to receptors in the placenta. This leads to a heavy accumulation of infected cells in the placental tissue, triggering inflammation that disrupts blood vessel formation, nutrient transport, and normal placental development. The consequences include miscarriage, stillbirth, restricted fetal growth, and low birth weight, all of which contribute to infant mortality. Placental malaria is especially dangerous for women in their first pregnancy, because they have not yet developed antibodies against VAR2CSA. With subsequent pregnancies, some immune protection builds up, and outcomes tend to improve.

Vulnerability to Other Infections

Malaria does not just weaken the body on its own. It actively opens the door to other pathogens. The immune suppression caused by hemozoin-loaded macrophages, combined with direct damage to the gut, can make malaria patients dangerously susceptible to bacterial infections. Animal studies have shown that malaria infection disrupts intestinal tissue integrity, causing breaks in the gut lining, increased inflammatory signaling, and impaired neutrophil function. In co-infected animals, these changes rendered the host highly susceptible to bloodstream invasion by Salmonella. This is clinically relevant: in sub-Saharan Africa, invasive bacterial infections, particularly non-typhoidal Salmonella, are a recognized complication of malaria, especially in children.

How Human Genetics Adapted to the Threat

Malaria has been killing humans for so long that it has left its fingerprint on the human genome. The most famous example is sickle cell trait. Carrying one copy of the sickle hemoglobin gene, as opposed to two copies which cause sickle cell disease, provides substantial protection against severe falciparum malaria. The mechanism has been worked out in some detail: when infected red blood cells containing sickle hemoglobin travel into the low-oxygen environment of the body’s small blood vessels, the hemoglobin polymerizes. This arrests parasite growth at a specific stage before it can replicate its DNA, effectively stunting the infection.

But sickle hemoglobin is not the only line of defense. Research has uncovered additional mechanisms of protection, including enhanced tolerance to disease mediated by certain enzymes and, intriguingly, the transfer of host microRNA molecules into the parasite that may interfere with its biology. Other genetic variants common in malaria-endemic regions, including certain thalassemias and red blood cell membrane protein variations, appear to offer partial protection through related but distinct mechanisms. The cost is significant: these same genetic variants can cause serious blood disorders when inherited in certain combinations. It is one of the clearest examples in human biology of an evolutionary arms race between a parasite and its host, where the host pays a genetic tax for survival.